Jefferson Torresdale Hospital is a non-profit hospital in the Jefferson Health Northeast system, a multi-state non-profit health system now a part of Jefferson Health. The hospital serve as a general hospital of Aria-Jefferson Health and is a Level II trauma center. The hospital contains a helipad for transport.

There are 258 beds in Jefferson Torresdale Hospital.

During the past decade, Jefferson Torresdale Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 16 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jefferson Torresdale Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "NRG Oncology" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Canadian Cancer Trials Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jefferson Torresdale Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Jefferson Torresdale Hospital" are "Invasive Breast Carcinoma" (4 trials), "Stage IIA Breast Cancer" (3 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer" (3 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials). Many other conditions were trialed in "Jefferson Torresdale Hospital" in a lesser frequency.

Most popular intervention types in "Jefferson Torresdale Hospital" are "Drug" (37 trials), "Other" (34 trials), "Radiation" (25 trials), "Biological" (21 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (15 trials), "Radiation Therapy" (8 trials), "Bevacizumab" (7 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Jefferson Torresdale Hospital" are 34 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Jefferson Torresdale Hospital". undefined are not yet recruiting, 9 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Jefferson Torresdale Hospital, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Jefferson Torresdale Hospital, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".